These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25916464)

  • 41. Induction therapy before transplantation in multiple myeloma: new strategies to achieve complete response.
    Wu KL; Sonneveld P
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):96-101. PubMed ID: 16231847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112.
    Chou T; Tobinai K; Uike N; Asakawa T; Saito I; Fukuda H; Mizoroki F; Ando K; Iida S; Ueda R; Tsukasaki K; Hotta T;
    Jpn J Clin Oncol; 2011 Apr; 41(4):586-9. PubMed ID: 21247967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myeloma.
    Moreau P
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):885-90. PubMed ID: 19589027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [IgD myeloma manifesting as acute renal insufficiency].
    Duvic C; Sarret D; De Revel T; Hérody M; Didelot F; Labaye J; Nédélec G
    Rev Med Interne; 2000 Sep; 21(9):799-803. PubMed ID: 11039177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An unusual endoscopic finding in a patient with melena: multiple gastric ulcers of regular shape.
    Carbone M; Buccisano F; Lenci I; Baiocchi L
    Dig Liver Dis; 2013 Jan; 45(1):e1. PubMed ID: 22951315
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extramedullary relapse of multiple myeloma presenting as massive upper gastrointestinal bleeding: a rare complication.
    Yasar B; Gunes P; Guler O; Yagcı S; Benek D
    Korean J Intern Med; 2015 Jul; 30(4):538-9. PubMed ID: 26161021
    [No Abstract]   [Full Text] [Related]  

  • 48. Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients.
    Patriarca F; Sperotto A; Prosdocimo S; Geromin A; Zaja F; Fanin R
    Haematologica; 2003 May; 88(5):597-9. PubMed ID: 12745281
    [No Abstract]   [Full Text] [Related]  

  • 49. Bilateral central retinal vein occlusion associated with multiple myeloma.
    Aggio FB; Cariello AJ; Almeida MS; Rodrigues CA; De Moraes NS; Colleoni GW; Farah ME
    Ophthalmologica; 2004; 218(4):283-7. PubMed ID: 15258420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remission of collapsing focal segmental glomerulosclerosis following chemotherapy for myeloma.
    Shah S; Cavenagh J; Sheaf M; Thuraisingham RC
    Am J Kidney Dis; 2004 Feb; 43(2):e10-2. PubMed ID: 14750118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloma and the newly diagnosed patient: a focus on treatment and management.
    Rajkumar SV; Kyle RA; Gertz MA
    Semin Oncol; 2002 Dec; 29(6 Suppl 17):5-10. PubMed ID: 12520478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of multiple myeloma in the targeted therapy era.
    Saad AA; Sharma M; Higa GM
    Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hematopoietic stem cell transplantation for multiple myeloma].
    Kanda Y
    Rinsho Ketsueki; 2009 Oct; 50(10):1420-6. PubMed ID: 19915350
    [No Abstract]   [Full Text] [Related]  

  • 54. [Extraskeletal diffusion of multiple myeloma. A clinico-pathological description of 4 cases].
    Cantore M; Smerieri F; Bucalossi A; Leoncini L
    Recenti Prog Med; 1991 Nov; 82(11):598-602. PubMed ID: 1763233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recent therapy for refractory myeloma].
    Togawa A
    Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Could the VAD protocol be the first line therapy for multiple myeloma in subSaharan Africa? The Brazzaville experience].
    Dokekias AE
    Sante; 2011; 21(3):169-70. PubMed ID: 22396958
    [No Abstract]   [Full Text] [Related]  

  • 57. Diagnosis and management of multiple myeloma.
    UK myeloma forum. British Committee for Standards in Haematology
    Br J Haematol; 2001 Dec; 115(3):522-40. PubMed ID: 11736932
    [No Abstract]   [Full Text] [Related]  

  • 58. [Recent progress in the treatment of hematological malignancies. V. Therapy of multiple myeloma].
    Imamura Y
    Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):809-13. PubMed ID: 2677178
    [No Abstract]   [Full Text] [Related]  

  • 59. Is granulocyte-macrophage colony-stimulating factor (GM-CSF) safe in myelodysplastic syndromes?
    Mittelman M; Floru S; Pick AI
    Haematologia (Budap); 1994; 26(2):111-5. PubMed ID: 7890261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.
    Ritchie DS; Seymour JF; Grigg AP; Roberts AW; Hoyt R; Thompson S; Szer J; Prince HM
    Ann Hematol; 2007 Feb; 86(2):101-5. PubMed ID: 17089127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.